Contrast-induced nephropathy: definition, epidemiology, and patients at risk.

Radiological procedures utilizing intravascular iodinated contrast media injections are being widely applied for both diagnostic and therapeutic purposes. This has resulted in an increasing incidence of procedure-related contrast-induced nephropathy (CIN). The definition of CIN includes absolute (> or = 0.5 mg/dl) or relative increase (> or = 25%) in serum creatinine at 48-72 h after exposure to a contrast agent compared to baseline serum creatinine values, when alternative explanations for renal impairment have been excluded. Although the risk of renal function impairment associated with radiological procedures is low (0.6-2.3%) in the general population, it may be very high in selected patient subsets (up to 20%), especially in patients with underlying cardiovascular disease. This review provides information on the known risk factors for the development of CIN, and completes with describing user-friendly CIN risk score based on the readily available information.

[1]  M. Hlatky,et al.  Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. , 1989, The New England journal of medicine.

[2]  B. Barrett,et al.  Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.

[3]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[4]  E. Bates,et al.  Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  P. Parfrey,et al.  Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.

[6]  E C Lasser,et al.  Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. , 1997, Radiology.

[7]  W. O’Neill,et al.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study , 1999 .

[8]  K. Browne,et al.  Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. , 1996, American heart journal.

[9]  M. Wolverson,et al.  Analysis of Radiocontrast-Induced Nephropathy by Dual-Labeled Radionuclide Clearance , 1994, Investigative radiology.

[10]  Y. Wang,et al.  Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. , 1990, The American journal of medicine.

[11]  Ruddle Fh,et al.  Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6. , 1976, Cytogenetics and cell genetics.

[12]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[13]  J. Lemke,et al.  Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. , 1991, Radiology.

[14]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[15]  F. Veglia,et al.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[16]  V. Bernhard,et al.  Contrast-induced nephrotoxicity: the effects of vasodilator therapy. , 1992, The Journal of surgical research.

[17]  Samin K. Sharma,et al.  A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: Effect of selective dopamine receptor agonist fenoldopam , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  G. Dangas,et al.  Acute renal failure requiring dialysis after percutaneous coronary interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  G. Stone,et al.  Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. , 2004, The American journal of cardiology.

[20]  B. Rutherford,et al.  High-dose contrast agent administration during complex coronary angioplasty. , 1990, American heart journal.

[21]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[22]  Douglas Losordo,et al.  Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). , 2002, The American journal of cardiology.

[23]  A. S. Berns,et al.  Nephrotoxicity of contrast media. , 1989, Kidney international.

[24]  J. H. van Bockel,et al.  Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease. , 1991, The Journal of cardiovascular surgery.

[25]  William W O'Neill,et al.  Determinants of serum creatinine trajectory in acute contrast nephropathy. , 2002, Journal of interventional cardiology.

[26]  S. Pocock,et al.  Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. , 2005, Kidney international.

[27]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[28]  H. Rusinek,et al.  High-dose administration of nonionic contrast media: a retrospective review. , 1996, Radiology.

[29]  P. McCullough,et al.  Epidemiology of contrast-induced nephropathy. , 2003, Reviews in cardiovascular medicine.

[30]  A. Schoenfeld,et al.  Radiocontrast-associated renal dysfunction: incidence and risk factors. , 1991, AJR. American journal of roentgenology.

[31]  G. Taylor,et al.  Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings. , 1993, Radiology.

[32]  G. Stone,et al.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. , 2005, The American journal of cardiology.

[33]  M. Rich,et al.  Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. , 1990, Archives of internal medicine.

[34]  Sven-Göran Fransson,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[35]  S. Hou,et al.  Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  T. Ahuja,et al.  Contrast-induced nephrotoxicity in renal allograft recipients. , 2000, Clinical nephrology.

[37]  C. Wegner,et al.  Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy. , 1997, Renal failure.